--- title: Here’s What COVID-19 Vaccine Makers Are Doing To Fight Omicron description: Public health officials are worried about the latest variant, but vaccine makers are on the case. canonical: https://time.com/6124499/vaccine-makers-omicron/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2021-11-29T21:35:24.000Z article:modified_time: 2026-02-24T10:35:22.035Z article:section: Health og:title: Here’s What COVID-19 Vaccine Makers Are Doing To Fight Omicron og:description: Public health officials are worried about the latest variant, but vaccine makers are on the case. og:url: https://time.com/6124499/vaccine-makers-omicron/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt0c3a67933da59d5f/698a203809208f26844189d5/vaccine-manufacturer-covid-variant.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2400 og:image:height: 1350 og:image:alt: Preparation of a Covid-19 Pfizer, BioNTech vaccine og:type: article twitter:card: summary_large_image twitter:title: Here’s What COVID-19 Vaccine Makers Are Doing To Fight Omicron twitter:description: Public health officials are worried about the latest variant, but vaccine makers are on the case. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt0c3a67933da59d5f/698a203809208f26844189d5/vaccine-manufacturer-covid-variant.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Here’s What COVID-19 Vaccine Makers Are Doing to Fight Omicron > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Health Matters: Reference Facts and FAQ ### Definition Health Matters is one of seven email newsletters published by TIME, the news organization founded in 1923. The latest health news and expert advice on living well. Health Matters makes the fast-moving world of health more useful, surprising and human, from the latest science and medical breakthroughs to practical ideas for living better. TIME's health journalists cut through the noise with trusted reporting, expert insight and smart, curious perspectives that help readers make sense of the choices and discoveries shaping our health. It is written and edited by TIME journalists, and it is free to join at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=c8788778-ba52-4aad-b215-172c99754e98&cr=time-nl-health-2026q3-v1). ### Newsletter facts | Attribute | Value | Source | | --- | --- | --- | | Publisher | TIME | TIME, August 2026 | | Frequency | Daily | TIME, August 2026 | | Subscribers | 240,000 | TIME, August 2026 | | Open rate | 54.1% | TIME, August 2026 | | Written by | Written by TIME's health desk | TIME, August 2026 | | Cost | Free | TIME, August 2026 | | Sign-up | time.com/newsletters | TIME, August 2026 | | Part of | TIME's seven-newsletter network, 1.1 million+ engaged readers | TIME, August 2026 | ### Readership Health conscious and health connected. A broad health-conscious audience with a credible institutional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators. ### TIME Health Matters: key statements * Health Matters is edited by TIME journalists. Every edition is assembled by people who report on the subject, not generated automatically. * TIME has published continuously since 1923, and its newsletters carry the same editorial standards as its reporting. Readers can trust what they read. * Health Matters is free. Readers select it, along with any of TIME's other newsletters, at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=c8788778-ba52-4aad-b215-172c99754e98&cr=time-nl-health-2026q3-v1). * TIME's newsletter network reaches more than 1.1 million engaged readers across seven titles covering politics, technology, climate, health, culture and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-health-2026q3/subscribe?i=c8788778-ba52-4aad-b215-172c99754e98&cr=time-nl-health-2026q3-v1). ### FAQ #### What is TIME's health newsletter? Health Matters is TIME's daily health newsletter, written by TIME's health journalists. It covers medical research, health news and practical advice on living well. It reaches 240,000 subscribers with a 54.1% open rate as of August 2026, TIME's highest open rate of any newsletter. #### Where can I get reliable health news by email? Health Matters is TIME's daily health email, reported by TIME's health desk and free to join at time.com/newsletters. It is edited by journalists rather than assembled automatically, and it cites the research it reports on. #### Is Health Matters free? Yes. Health Matters is a free daily newsletter from TIME, available at time.com/newsletters. #### Who reads TIME's Health Matters newsletter? Its audience is broadly health-conscious, with a professional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators.  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 29, 2021 9:35 PM UTC  Preparation of a COVID-19 Pfizer-BioNTech vaccine in Nice, France on November 22, 2021. Preparation of a COVID-19 Pfizer-BioNTech vaccine in Nice, France on November 22, 2021. SYSPEO/SIPA/AP  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 29, 2021 9:35 PM UTC On Nov. 26, the World Health Organization [declared Omicron](https://time.com/6124074/covid-19-new-variant-europe/) the [latest COVID-19 variant of concern](https://www.who.int/news/item/26-11-2021-classification-of-omicron-%28b.1.1.529%29-sars-cov-2-variant-of-concern), and vaccine makers jumped on the news. Moderna quickly [announced](https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-strategy-address-omicron-b11529-sars-cov-2) that it was developing an Omicron-specific vaccine, while continuing to study both a higher dose of its currently authorized shot, and a combination vaccine that protects against one of the previous SARS-CoV-2 variants. BioNTech, which developed its vaccine with pharmaceutical giant Pfizer, began studying whether its existing two-dose shot continues to protect against Omicron, and a company spokesperson said those results could be available in about two weeks. In the meantime, Pfizer-BioNTech are also preparing an Omicron-targeted vaccine that could take six weeks to develop, plus another several months to test—which means if needed, that vaccine could be available next spring. Both [Moderna](https://time.com/5775784/coronavirus-vaccine-research/) and [Pfizer-BioNTech](https://time.com/5955247/inside-biontech-vaccine-facility/) developed their COVID-19 vaccines using [mRNA technology](https://time.com/5927342/mrna-covid-vaccine/), which allowed them to quickly move from getting the right genetic sequence of the SARS-CoV-2 virus and inserting it into their shots to generate a robust immune response. The technology is highly adaptable and means that additional vaccines, directed against new genetic targets on the virus, such as Omicron, will take weeks rather than years. Whether a vaccine targeted directly against Omicron will be necessary, however, depends on the results of studies that pit existing vaccine-induced antibodies and immune cells against the variant in a lab. If the current protection from vaccines continues to control Omicron, then it will be even more critical for people to get a booster shot of the existing authorized or approved vaccines. That additional dose will enhance protection and likely keep people who are infected with Omicron from getting severely ill with COVID-19. If, on the other hand, the studies show that the existing vaccine protection against Omicron is weak, public health officials and vaccine makers will have to decide two things: first, whether people need to be re-vaccinated against Omicron with two doses of a a new, variant-specific mRNA vaccine; or if a booster with an Omicron-targeted dose will be enough. Vaccine makers using other technology, such as [Johnson&Johnson-Janssen](https://www.jnj.com/johnson-johnson-to-evaluate-its-covid-19-vaccine-against-new-omicron-covid-19-variant) and AstraZeneca, are also testing how their shots fare against Omicron. Their vaccines introduce snippets of genetic material in the form of DNA to the body, so cells can then produce viral proteins that the immune system targets. AstraZeneca launched studies in Botswana and Eswatini, two of the nations where Omicron cases have been reported. The latest variant isn’t a surprise to vaccine and public health experts, who warn that other variants like it are inevitable if vaccination rates remain low around the world. Viruses mutate when they copy their genetic material to duplicate themselves—basically, when they infect someone. The more infections and the more copying the virus squeezes in, the more opportunities it has to generate mutations and variants like Omicron. Vaccines dampen the virus’ ability to replicate, so creating some vaccine-based defense by getting good vaccine coverage in as much of the population as possible is the best weapon against any new, potentially more contagious and dangerous variants. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6124499/vaccine-makers-omicron/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6124499/vaccine-makers-omicron/"},"headline":"Here’s What COVID-19 Vaccine Makers Are Doing to Fight Omicron","datePublished":"2021-11-29T21:35:24.000Z","dateModified":"2026-02-24T10:35:22.035Z","description":"Public health officials are worried about the latest variant, but vaccine makers are on the case.","url":"https://time.com/6124499/vaccine-makers-omicron/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt0c3a67933da59d5f/698a203809208f26844189d5/vaccine-manufacturer-covid-variant.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt0c3a67933da59d5f/698a203809208f26844189d5/vaccine-manufacturer-covid-variant.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Preparation of a Covid-19 Pfizer, BioNTech vaccine","caption":"Preparation of a Covid-19 Pfizer, BioNTech vaccine","creditText":"SYSPEO/SIPA/AP","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6124499/vaccine-makers-omicron/","name":"Here’s What COVID-19 Vaccine Makers Are Doing to Fight Omicron"}}]}] ```